Target intelligence / Profile preview

Uncoordinated-119 lipid binding chaperone (UNC119)

Target
UNC119
Molecular classification
Other (lipid binding chaperone), transporter (cargo adapter for lipid-modified proteins)
01

Overview

Uncoordinated-119 lipid binding chaperone (UNC119, also known as HRG4) is a lipid-binding cargo adapter protein found in many species, including humans, where it is encoded on chromosome 17[2][1][4][6]. UNC119 specifically binds to myristoylated proteins and is required for their correct localization, especially to cilia and photoreceptor synapses in the retina[1][2][3][6]. This protein plays a key role in processes such as cilium assembly, protein trafficking, and the maintenance of photoreceptor function in the eye. It is also implicated in synaptic signaling and neuronal development, immune cell signal transduction (as an activator of Src family kinases in T cells), and endosome recycling[2][6]. Mutations in UNC119 are associated with disorders such as retinitis pigmentosa and Joubert syndrome, and may affect immune function[1][2]. There are no known drugs directly targeting UNC119, nor is it currently validated as a therapeutic target, but it is a key component of intracellular lipid-binding transport systems.

Other names
Retinal protein 4HRG4POC7 centriolar protein homolog AIMD13POC7ARG4
02

Biological functions

Lipid bindingcilium assemblyprotein traffickingsynaptic vesicle cycle regulationsignal transductionendosome recycling
03

Disease associations

Retinal disorders (such as retinitis pigmentosa)Joubert syndromepossible immunodeficiency (idiopathic CD4 lymphopenia)neurodevelopmental disorders

Beyond the preview

Go deeper on Uncoordinated-119 lipid binding chaperone (UNC119).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uncoordinated-119 lipid binding chaperone (UNC119).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call